Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Expression of Interferon Pathway Genes CXCL10 and STAT2 Is Associated with Activated T-Cell Signature and Better Outcome of Oral Cancer Patients. | J Pers Med | 2022 | 35207629 | PubTator, text mining | PubMed |
| Identification and Validation of Pathogenic Genes in Sepsis and Associated Diseases by Integrated Bioinformatics Approach. | Genes (Basel) | 2022 | 35205254 | PubTator, text mining | PubMed |
| A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene? | Antioxidants (Basel) | 2022 | 35204159 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Polarised Macrophages Derived from Induced Pluripotent Stem Cells. | Biomedicines | 2022 | 35203449 | PubTator, text mining | PubMed |
| Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection. | Nat Commun | 2022 | 35197461 | PubTator, text mining | PubMed |
| Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4+ T cells in systemic sclerosis via IRF1 signaling. | Arthritis Res Ther | 2022 | 35183246 | PubTator, text mining | PubMed |
| Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes. | Nat Commun | 2022 | 35173148 | PubTator, text mining | PubMed |
| Comparative Transcriptional Analysis Identified Characteristic Genes and Patterns in HIV-Infected Immunological Non-Responders. | Front Immunol | 2022 | 35154126 | PubTator, text mining | PubMed |
| Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccine. | Cell Rep | 2022 | 35139383 | PubTator, text mining | PubMed |
| Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection. | Proc Natl Acad Sci U S A | 2022 | 35131898 | PubTator, text mining | PubMed |
| Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis. | Br J Clin Pharmacol | 2022 | 35122284 | PubTator, text mining | PubMed |
| Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. | Nat Commun | 2022 | 35115549 | PubTator, text mining | PubMed |
| Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. | iScience | 2022 | 35106453 | PubTator, text mining | PubMed |
| Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis. | J Int Med Res | 2022 | 35086375 | PubTator, text mining | PubMed |
| Identification of potentially anti-COVID-19 active drugs using the connectivity MAP. | PLoS One | 2022 | 35085325 | PubTator, text mining | PubMed |
| Advances in understanding of the innate immune response to human norovirus infection using organoid models. | J Gen Virol | 2022 | 35077345 | PubTator, text mining | PubMed |
| Bioinformatic Analysis Identifies Biomarkers and Treatment Targets in Primary Sjögren's Syndrome Patients with Fatigue. | Biomed Res Int | 2022 | 35075430 | PubTator, text mining | PubMed |
| Betacoronavirus-specific alternate splicing. | Genomics | 2022 | 35074468 | PubTator, text mining | PubMed |
| Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. | Mol Neurodegener | 2022 | 35073950 | PubTator, text mining | PubMed |
| Sunscreens with the New MCE Filter Cover the Whole UV Spectrum: Improved UVA1 Photoprotection In Vitro and in a Randomized Controlled Trial. | JID Innov | 2022 | 35072138 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=35